Now showing items 1-1 of 1
Paklitaksel Nanopartiküllerinin Kalite Tasarımı Ile Geliştirilmesi ve Değerlendirilmesi
(Sağlık Bilimleri Enstitüsü, 2013)
Quality by design is an FDA initiative that is a science and knowledge-based approach to pharmaceutical development. The aim of this study was to develop and characterize paclitaxel nanoparticles prepared by o/w ...